-+ 0.00%
-+ 0.00%
-+ 0.00%

CAN-FITE REPORTS Q2 2026 FINANCIAL RESULTS AND ONGOING CLINICAL PROGRESS HIGHLIGHTING LONGER-THAN-ANTICIPATED OVERALL SURVIVAL IN ONGOING PIVOTAL PHASE III LIVER CANCER STUDY

Reuters·09/08/2026 12:20:00

Please log in to view news